- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01389934
Infusion of a Local Anaesthetic in the Surgical After Modified Radical Mastectomy With Expander
Background: The use of local anesthetics as a supplement to conventional techniques in breast surgery is widely reported in the literature. Currently there is controversy regarding the efficacy of surgery for breast infusion of local anesthetic after surgery. The aim of this study demonstrate the efficacy of administering a local anesthetic into the surgical bed of women operated radical mastectomy for breast cancer for the control of postoperative pain.
Material and methods: double-blind randomized clinical trial. The investigators recruited patients who underwent modified radical mastectomy that met inclusion and exclusion criteria. The intervention group were infused with L-bupivacaine 0.50% 2 ml/h for 48 hours, and saline control group at 2 ml/h during surgery and anesthetic technique 48 hours. Local anesthetic and rescue medication was identical in both groups.
Statistical analysis: The baseline patient characteristics of the patients were analyzed by Chi square or Student t always meet criteria of normality, otherwise it will use the Mann-Whitney. To determine the effectiveness of treatment as well as pain scale adverse events will be held on chi-square test.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Alava
-
Vitoria-gasteiz, Alava, Spain, 01009
- Txagorritxu Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients diagnosed with operable breast cancer, which will be submitted to modified radical mastectomy
- Sign informed consent.
Exclusion Criteria:
- Mastectomy without lymphadenectomy
- Over 80 years
- Cognitive impairment and patients with serious psychiatric disorders before diagnosis of the cancer process
- Severe liver or kidney disease
- Patients allergic or intolerant to any of the drugs used in the study protocol.
- Regular users of analgesics or narcotics
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control
Women of this group be infused saline 2 ml / h for 48h.
|
Women of this group be infused saline 2 ml / h for 48h.
|
|
Experimental: levo-bupicaine
Women of this group will be infused L-bupivacaine 0.50% 2 ml / h for 48h.
|
Women of this group will be infused L-bupivacaine 0.50% 2 ml / h for 48h after intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
effectiveness of administering levo-bupicaine to control postoperative pain.
Time Frame: 48 hours
|
the control postoperative pain will be measured by a a patient satisfaction scale (very good, good, fair, bad, very bad)
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Decreased consumption of other analgesics
Time Frame: 48 hours
|
We will measure the number of rescue doses of each drug (acetoaminphen, metamizol, dexketoprofen and morphine) We will include all minor adverse effects (nausea, vomiting ...) as severe (sedacion..) and their resolution.
|
48 hours
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Ferreira Laso L, Lopez Picado A, Antonanzas Villar F, Lamata de la Orden L, Ceballos Garcia M, Ibanez Lopez C, Pipaon Ruilope L, Lamata Hernandez F, Valero Martinez C, Aizpuru F, Hernandez Chaves R. Cost-effectiveness analysis of levobupivacaine 0.5 %, a local anesthetic, infusion in the surgical wound after modified radical mastectomy. Clin Drug Investig. 2015 Sep;35(9):575-82. doi: 10.1007/s40261-015-0316-4.
- Ferreira Laso L, Lopez-Picado A, Lamata L, Ceballos Garcia M, Ibanez Lopez C, Pipaon Ruilope L, Lamata Hernandez F, Antonanzas Villar F, Valero Martinez C, Aizpuru F, Hernanz Chaves R. Postoperative analgesia by infusion of local anesthetic into the surgical wound after modified radical mastectomy: a randomized clinical trial. Plast Reconstr Surg. 2014 Dec;134(6):862e-870e. doi: 10.1097/PRS.0000000000000762.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MASTEC-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Local Anesthetic
-
The Cleveland ClinicCompleted
-
Sintetica SACross Research S.A.Completed
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedAnesthesia, Local | Local Anesthetic Systemic ToxicityItaly
-
Al-Azhar UniversityCompletedLocal Anesthetic ComplicationEgypt
-
Cairo UniversityRecruitingLocal Anesthetic ComplicationEgypt
-
University of TorontoAnesthesia Research FoundationCompleted
-
University of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São PauloCompletedLocal Anesthetic EffectivenessBrazil
-
University of Campania "Luigi Vanvitelli"CompletedLocal Anesthetic EfficacyItaly
-
Lawson Health Research InstituteNot yet recruitingRegional Anesthesia | Local Anesthetic
-
Aretaieion University HospitalRecruitingCesarean Section | Local AnestheticGreece
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AkesoNot yet recruitingAtopic DermatitisChina
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States